Delivery Order SPE2DB20D3303-SPE2DB25FA3KB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Albuterol HFA 90 MCG Inhaler in 8.5GM units, valued at $1,518.96. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) with a ceiling value of $4,328.64. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by August 18, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Albuterol HFA 90 mcg inhaler 8.5 gm with a ceiling value of $1,269.74. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction under an open procurement process. The order is scheduled for ultimate completion by September 15, 2025, with performance taking place at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,849.06 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG inhalers (8.5GM) on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under DLA's medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Albuterol HFA 90 MCG Inhalers (8.5 GM) with a ceiling value of $1,373.40. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is set to complete by July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) at a ceiling value of $1,585.92. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a direct procurement under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. No set-aside designation was applied to this award, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $1,658.88 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG Inhaler 8.5GM on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply delivery under the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Albuterol HFA 90 MCG inhaler 8.5GM with a ceiling value of $1,223.54. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract has an ultimate completion date of September 5, 2025, and performance will occur at the vendor's Conshohocken facility. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Albuterol HFA 90 mcg inhalers in 8.5-gram units, with a ceiling value of $1,026.95 under a firm fixed price contract structure. This delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 20, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $2,063.72 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 mcg inhaler in 8.5 gram units. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. As a non-set-aside contract, this award was made through open...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3KBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, valued at $1,665.03. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, with a completion deadline of September 9, 2025. The award represents a continuation of AmerisourceBergen's substantial role in federal pharmaceutical procurement, where the company serves as a critical vendor for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally. The IDC supports military healthcare programs and other federal customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent receipt of competitively awarded delivery orders for medications across multiple therapeutic domains demonstrates the company's established capability to meet federal medical supply requirements efficiently and reliably.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/8/25 |